Immunomedics, Inc. Gains 97.99%
Mon, Sep 14, 2020 at 05:36 PM
Immunomedics, Inc. (IMMU:NASDAQ) jumped higher at $83.65, a gain of 98%. The stock got featured on our News Catalysts scanner on Mon 14 Sep 20 at 04:24 PM in the 'BIOTECH' category. From Fri 28 Aug 20, the stock recorded 44.44% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Immunomedics, Inc. (IMMU:NASDAQ)
Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.
Top 10 Gainers:
- Cassava Sciences, Inc. (SAVA:NASDAQ), 133.43%
- Immunomedics, Inc. (IMMU:NASDAQ), 97.99%
- Vaxart, Inc. (VXRT:NASDAQ), 46.79%
- NextDecade Corporation (NEXT:NASDAQ), 46.31%
- Scientific Games Corporation (SGMS:NASDAQ), 39.33%
- J.Jill, Inc. (JILL:NYSE), 37.51%
- Mersana Therapeutics, Inc. (MRSN:NASDAQ), 29.6%
- CBAK Energy Technology, Inc. (CBAT:NASDAQ), 26.16%
- Select Energy Services, Inc. (WTTR:NYSE), 25.56%
- Evogene Ltd. (EVGN:NASDAQ), 24.88%